6176 - 6200 of 7877 Results
Title
Year
- Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression2016OPENTitle: Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progressionJournal Name: PROTEOMICSPublisher: WileyVol: 16Issue #: 23Start Page: 3042End Page: 3053Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201600057Best OA location URL: https://europepmc.org/articles/pmc5462625?pdf=renderCitation Count: 77
-
OPENTitle: Dual Tasking for the Differentiation between Depression and Mild Cognitive ImpairmentJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00235Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00235/pdfCitation Count: 18
-
OPENTitle: Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson’s DiseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 10Start Page: e0162799End Page: e0162799Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0162799Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0162799&type=printableCitation Count: 93
-
OPENTitle: mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep35106Best OA location URL: https://doi.org/10.1038/srep35106Citation Count: 71
- Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease2016RESTRICTEDTitle: Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 360Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aad8858Citation Count: 63
- Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance2016OPENTitle: Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritanceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: ddw348End Page: ddw348Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddw348Best OA location URL: https://academic.oup.com/hmg/article-pdf/25/24/5483/10408585/ddw348.pdfCitation Count: 49
-
OPENTitle: Machine Learning Interface for Medical Image AnalysisJournal Name: Journal of Digital ImagingPublisher: Springer Science and Business Media LLCVol: 30Issue #: 5Start Page: 615End Page: 621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10278-016-9910-0Best OA location URL: https://europepmc.org/articles/pmc5603426?pdf=renderCitation Count: 57
-
RESTRICTEDTitle: Neuropsychological impairment in prodromal Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 371Issue #:Start Page: 117End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007Citation Count: 14
- Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases2016OPENTitle: Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseasesJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/sdata.2016.89Best OA location URL: https://www.nature.com/articles/sdata201689.pdfCitation Count: 393
- Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease2016OPENTitle: Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 34Issue #:Start Page: 15End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.10.006Best OA location URL: https://europepmc.org/articles/pmc5222688?pdf=renderCitation Count: 32
- N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase2016OPENTitle: N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 96Issue #:Start Page: 323End Page: 334Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.10.001Best OA location URL: https://europepmc.org/articles/pmc5102763?pdf=renderCitation Count: 32
- Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans2016OPENTitle: Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegansJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep34477Best OA location URL: https://www.nature.com/articles/srep34477.pdfCitation Count: 366
- Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration2016OPENTitle: Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degenerationJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 1Start Page: 115End Page: 123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26815Best OA location URL: https://europepmc.org/articles/pmc5269612?pdf=renderCitation Count: 53
-
OPENTitle: Computer keyboard interaction as an indicator of early Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep34468Best OA location URL: https://doi.org/10.1038/srep34468Citation Count: 90
-
RESTRICTEDTitle: AAV viral vector delivery to the brain by shape-conforming MR-guided infusionsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 240Issue #:Start Page: 434End Page: 442Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2016.02.034Citation Count: 36
- Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbations2016RESTRICTEDTitle: Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 603End Page: 616Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2016.02.033Best OA location URL: https://doi.org/10.1016/j.brainres.2016.02.033Citation Count: 39
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum2016OPENTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Best OA location URL: https://europepmc.org/articles/pmc5018437?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Gene therapy to target ER stress in brain diseasesJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 561End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.064Citation Count: 31
-
RESTRICTEDTitle: Injury to the nervous system: A look into the ERJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 617End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.053Citation Count: 24
- LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives2016RESTRICTEDTitle: LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesJournal Name: Clinical Pharmacology: Advances and ApplicationsPublisher: Informa UK LimitedVol: Volume 8Issue #:Start Page: 177End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cpaa.s102191Best OA location URL: https://www.dovepress.com/getfile.php?fileID=33080Citation Count: 41
-
OPENTitle: Perspective: Data sharing for discoveryJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 538Issue #: 7626Start Page: S4End Page: S4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/538s4aBest OA location URL: https://www.nature.com/articles/538S4a.pdfCitation Count: 6
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://europepmc.org/articles/pmc5410378?pdf=renderCitation Count: 24
-
RESTRICTEDTitle: The best medicine? The influence of physical activity and inactivity on Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1444End Page: 1454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491025Citation Count: 97
- Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease2016RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 54
- Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes2016OPENTitle: Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 33Issue #:Start Page: 107End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.09.025Best OA location URL: https://europepmc.org/articles/pmc5154808?pdf=renderCitation Count: 24